Presentation is loading. Please wait.

Presentation is loading. Please wait.

From: Parvovirus B19–Related Anemia in an HIV-Infected Patient: Rapid Control after Production of Neutralizing Antibodies during Highly Active Antiretroviral.

Similar presentations


Presentation on theme: "From: Parvovirus B19–Related Anemia in an HIV-Infected Patient: Rapid Control after Production of Neutralizing Antibodies during Highly Active Antiretroviral."— Presentation transcript:

1 From: Parvovirus B19–Related Anemia in an HIV-Infected Patient: Rapid Control after Production of Neutralizing Antibodies during Highly Active Antiretroviral Therapy Ann Intern Med. 2000;132(12):1011. doi: / Figure Legend: Temporal relation among highly active antiretroviral therapy (HAART), plasma HIV RNA levels, CD4cell counts, hemoglobin level, parvovirus B19 viremia, parvovirus B19 IgG and IgM, intravenous immunoglobulin therapy, and transfusion of packed red blood cells (RBC) in a patient treated simultaneously for HIV and parvovirus B19 co-infection. Date of download: 11/11/2017 Copyright © American College of Physicians. All rights reserved.


Download ppt "From: Parvovirus B19–Related Anemia in an HIV-Infected Patient: Rapid Control after Production of Neutralizing Antibodies during Highly Active Antiretroviral."

Similar presentations


Ads by Google